Norinchukin Bank The lifted its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 43.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 101,729 shares of the semiconductor company's stock after purchasing an additional 30,894 shares during the period. Norinchukin Bank The's holdings in Lam Research were worth $7,396,000 at the end of the most recent quarter.
Other hedge funds have also recently modified their holdings of the company. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Lam Research in the 1st quarter worth approximately $26,000. West Paces Advisors Inc. purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $27,000. Mpwm Advisory Solutions LLC purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $27,000. Park Square Financial Group LLC purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $31,000. Finally, Putney Financial Group LLC purchased a new stake in shares of Lam Research in the 4th quarter worth approximately $36,000. Hedge funds and other institutional investors own 84.61% of the company's stock.
Lam Research Stock Performance
Shares of LRCX opened at $99.15 on Thursday. The stock has a 50-day moving average of $98.06 and a two-hundred day moving average of $84.32. Lam Research Corporation has a one year low of $56.32 and a one year high of $108.02. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The stock has a market cap of $125.49 billion, a P/E ratio of 23.83, a P/E/G ratio of 1.30 and a beta of 1.65.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company had revenue of $5.17 billion during the quarter, compared to analysts' expectations of $4.99 billion. During the same quarter in the previous year, the firm posted $1.03 EPS. The firm's revenue was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on LRCX. Deutsche Bank Aktiengesellschaft set a $70.00 price target on shares of Lam Research and gave the stock a "hold" rating in a research report on Thursday, April 24th. Barclays set a $83.00 price objective on shares of Lam Research and gave the stock an "equal weight" rating in a research note on Monday, July 28th. Mizuho boosted their price objective on shares of Lam Research from $115.00 to $120.00 and gave the stock an "outperform" rating in a research note on Friday, August 1st. Needham & Company LLC boosted their price objective on shares of Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Finally, Summit Insights lowered shares of Lam Research from a "buy" rating to a "hold" rating in a research note on Thursday, July 31st. Twenty research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research has an average rating of "Moderate Buy" and a consensus target price of $107.09.
Read Our Latest Report on Lam Research
Lam Research Company Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Further Reading
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.